Wenmin Du
Biographic Data
| ID | 10021023 |
|---|---|
| NAME | Wenmin Du |
| GIVEN NAMES | Wenmin |
| FAMILY NAME | Du |
| SIGNATURE | DU W |
| AFFILIATIONS | Nanjing Medical University |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China
Background: The National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the impact of the 2019 NDPN on the innovation performance of Chinese biopharmaceutical firms. Methods: We used quarterly panel data from 96 listed biopha…
No prominent works on this page.
Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China
Background: The National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the impact of the 2019 NDPN on the innovation performance of Chinese biopharmaceutical firms. Methods: We used quarterly panel data from 96 listed biopha…
Biopharmaceutical (1 works) · Biotechnology and Related Fields (1 works) · China (1 works) · Drug industry (1 works) · Incentive (1 works) · Innovation Policy and RD (1 works) · Intellectual property (1 works) · Negotiation (1 works) · Pharmaceutical Economics and Policy (1 works)